GAPDH and early-onset autosomal dominant Alzheimer disease: The institutional review board (IRB) at each participating centre (Taipei Veterans General Hospital IRB (IRB No. 2013-04-044B) and Taiwan Adventist Hospital IRB (IRB No. 108-E-10)) approved the study protocol used to investigate whether blood GAPDH could be a biomarker of Alzheimer’s disease.